LeMaitre Vascular, Inc. Aktie News
Was hinter der Kursbewegung steckt Index
Industrie
tracken
LeMaitre Vascular, Inc. Aktie News
Neutral
GlobeNewsWire
●
10 Tage alt
BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.
Neutral
Seeking Alpha
●
15 Tage alt
LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President & Director Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Shaymus Contorno - Oppenheimer & Co. Inc., Research Division Rick Wise Nathan Treybeck - Wells Fargo ...
Neutral
GlobeNewsWire
●
16 Tage alt
BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.
Neutral
GlobeNewsWire
●
etwa ein Monat alt
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close.
Positiv
Seeking Alpha
●
2 Monate alt
LeMaitre Vascular remains a long-term compounder, delivering strong Q2 results with 15% sales growth, robust margins, and increased dividends. LMAT's investment thesis is supported by pricing power, an expanding product pipeline, disciplined capital allocation, and consistent reinvestment driving high returns on capital. Valuation is fair-to-full at current levels, with a $110-$111 price target...
Neutral
GlobeNewsWire
●
3 Monate alt
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences.
Positiv
The Motley Fool
●
4 Monate alt
LeMaitre (LMAT) Q2 Revenue Jumps 15%
Neutral
Seeking Alpha
●
4 Monate alt
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer George W.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
